Riccardo Cortese

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Vaccine Development. Top assignees: Glaxosmithkline Biologicals Sa, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riccardo Cortese. Retrieved from https://idiyas.com/inventor/riccardo-cortese

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 4)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 99(Granted Patents)

Location History:

Basel, IT (2022)
Basel, CH (2020 - 2023)
Rome, IT (1999 - 2024)

Company Filing History:

13 out of 545

Glaxosmithkline Biologicals Sa

patents

5 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

patents

2 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 1 out of 1

Instituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

5. 1 out of 1

Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

6. 1 out of 1

Istituto Di Recerche Di Biologia Moleculare P. Angeletti S.p.a.

patent

7. 1 out of 8

Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a.

Merck Sharp + Dohme Corp.

patents

10. 1 out of 1

Sabin Vaccine Institute

patent

11. 1 out of 133

University of Copenhagen

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Adenoviral Vectors

Poxviral Vaccines

Hepatitis C Vaccine

Filovirus Vaccines

Simian Adenovirus

Immunogenic Muteins

Ciliary Neurotrophic Factor

Malaria Antigen

Antigen Binding Proteins

Ebola Virus

Obesity Treatment

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

2. 11701422 - Expression systems (2023-07-18),

3. 11498956 - Fusion peptides with antigens linked to short fragments of invariant chain(CD74) (2022-11-15),

4. 11278614 - Poxviral vaccines (2022-03-22),

5. 11254711 - Adenovirus polynucleotides and polypeptides (2022-02-22),

6. 11254710 - Adenovirus polynucleotides and polypeptides (2022-02-22),

7. 11214599 - Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof (2022-01-04),

8. 10588961 - Poxviral vaccines (2020-03-17),

9. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines (2020-03-10),

10. 10576143 - Poxviral vaccines (2020-03-03),

11. 10544192 - Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof (2020-01-28),

12. 9895431 - Simian adenoviral vectors encoding malaria antigen (2018-02-20),

13. 9718863 - Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof (2017-08-01),

14. 9526777 - Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein (2016-12-27),

15. 8142794 - Hepatitis C virus vaccine (2012-03-27),

Title: The Innovative Mind of Riccardo Cortese

Introduction: Riccardo Cortese, a visionary inventor hailing from Rome, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Riccardo Cortese holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his diverse range of expertise and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Cortese has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many around the world.

Collaborations: Throughout his career, Riccardo Cortese has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the development of cutting-edge technologies and solutions.

Conclusion: Riccardo Cortese's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

Profile summary based on public USPTO records.